Page 92 - Multiple Sclerosis News Today

And Lisi advises a letter writer how to navigate a tricky situation involving alcoholism.

Neurologist Jeremy Chataway brings you the latest on important clinical trials in progressive MS that will help guide the field toward better treatments.

A neurology professor talks about the need to identify early biomarkers of MS, describes a three-stage model for the disease, and ponders how to define cure in this setting.

We always spend Thanksgiving weekend with my boyfriend’s best friend and his wife and her sister who has a drinking problem.

It was gutbusting-galore on Wednesday as hundreds of eager trail runners and walkers descended on Napier in a bid to raise some much-needed funds for...

MMJ Denies DEA Extension To Respond to Marijuana Lawsuit - DEA Ineptitude ...

People with multiple sclerosis and moderate-to-severe walking disability could engage in physical activity and improve their physical function with an adapted running frame, suggests new research.

A groundbreaking study in NPJ Digital Medicine demonstrates the superior accuracy of AI-based imaging in diagnosing and monitoring multiple sclerosis.

After nearly 40 years of enduring Multiple Sclerosis and its derived illnesses, Paul Haynie was called home on October 17, 2023 at age 71.

Shares of Clene Inc. (NASDAQ:CLNN – Get Free Report) have been given a consensus recommendation of “Buy” by the six analysts that are presently covering the stock, Marketbeat.com reports. Six investment analysts have rated the stock with a buy recommendation. The average 1 year target price among brokerages that have issued a report on the […]